Nur 6121 exams 1–3 – advanced practice nursing
i exam with questions and answers/plus a
rationale updated 2026 a+/instant download pdf
Table of Contents
1. Advanced Health Assessment and Diagnostic Reasoning
2. Pharmacotherapeutics for Primary Care
3. Advanced Pathophysiology of Chronic Conditions
4. Professional Role Development and Legal/Ethical Standards
5. Evidence-Based Practice and Clinical Decision-Making
1. An elderly patient with a history of heart failure presents with increased dyspnea and bilateral
pedal edema. After auscultating an S3 gallop, which diagnostic interpretation is most clinically
appropriate?
A. The presence of an S3 indicates early diastolic filling resistance common in healthy elderly
adults.
B. The S3 is a sensitive marker for left ventricular systolic dysfunction and increased filling
pressures.
C. The S3 indicates the need for immediate administration of calcium channel blockers to
decrease contractility.
D. The S3 suggests primary pulmonary hypertension requiring an urgent referral for right-heart
catheterization.
Answer: B
CORRECT ANSWER : B
, Rationale: An S3 gallop in an elderly patient with heart failure signifies ventricular dilation and
increased filling pressure, often associated with systolic dysfunction. Option A is incorrect as S3
is pathological in this age group, not a normal finding. Option C is inappropriate as calcium
channel blockers are generally avoided in heart failure with reduced ejection fraction, and D is
incorrect because the finding points to left-sided issues, not pulmonary hypertension.
2. A patient being treated for hypertension with an ACE inhibitor develops a persistent, dry cough.
What is the most likely mechanism, and what is the appropriate management strategy?
A. Bronchospasm due to bradykinin accumulation; switch the patient to an ARB.
B. Pulmonary edema due to fluid retention; increase the dose of the ACE inhibitor.
C. Histamine release secondary to mast cell activation; prescribe an antihistamine.
D. Direct airway irritation from the drug molecule; continue treatment as tolerance will develop.
Answer: A
CORRECT ANSWER : A
Rationale: ACE inhibitors prevent the breakdown of bradykinin, leading to its accumulation in
the lungs, which causes a dry cough. The standard management is to switch the patient to an
Angiotensin Receptor Blocker (ARB), which does not affect bradykinin metabolism. Options B,
C, and D are incorrect because they misidentify the mechanism and provide clinically
inappropriate management.
3. A 55-year-old patient with type 2 diabetes and stable chronic kidney disease (CKD) requires
medication adjustment. Which class of medication is prioritized for its renal protective benefits
in this clinical scenario?
A. Sulfonylureas
B. Thiazolidinediones
C. Sodium-glucose cotransporter-2 (SGLT2) inhibitors
D. Dipeptidyl peptidase-4 (DPP-4) inhibitors
Answer: C
CORRECT ANSWER : C
Rationale: SGLT2 inhibitors demonstrate significant renal protective effects in patients with
diabetes and CKD by reducing hyperfiltration and slowing disease progression. Sulfonylureas,
DPP-4 inhibitors, and Thiazolidinediones (Options A, B, and D) do not provide the same
, evidence-based renal protection and may have contraindications or limited benefits in advanced
CKD.
4. A patient presents with acute onset of severe, unilateral headache associated with photophobia
and nausea. Which finding in the physical examination would most strongly necessitate urgent
neuroimaging to rule out secondary pathology?
A. Normal neurological examination with history of similar headaches.
B. Presence of bilateral temporal tenderness and elevated ESR.
C. New-onset neurological deficit or "thunderclap" character of the headache.
D. Pain that is relieved by NSAIDs and dark, quiet environments.
Answer: C
CORRECT ANSWER : C
Rationale: A "thunderclap" headache or new-onset neurological deficit indicates a potential
intracranial emergency like subarachnoid hemorrhage or mass effect, requiring immediate
imaging. Option A describes a likely migraine, B suggests giant cell arteritis, and D is highly
characteristic of a primary migraine disorder.
5. A patient with persistent asthma is poorly controlled despite using a low-dose inhaled
corticosteroid (ICS). According to current GINA guidelines, what is the preferred next step in
management?
A. Increase the dose of the ICS.
B. Add a long-acting beta-agonist (LABA).
C. Add a short-acting beta-agonist (SABA) for daily use.
D. Transition to oral systemic corticosteroids.
Answer: B
CORRECT ANSWER : B
Rationale: For patients not controlled on low-dose ICS, the addition of a LABA is the preferred
step-up therapy to improve symptom control and lung function. Simply increasing the ICS dose
(Option A) is less effective than adding a controller agent, and daily SABA use (Option C) is
contraindicated. Systemic steroids (Option D) are reserved for severe exacerbations, not
maintenance.
, 6. A patient presents with elevated TSH and low free T4. Which laboratory finding would be most
consistent with Hashimoto's thyroiditis?
A. Elevated thyroglobulin antibodies.
B. Low serum thyroglobulin levels.
C. Suppressed thyroid-stimulating immunoglobulin (TSI).
D. Decreased erythrocyte sedimentation rate (ESR).
Answer: A
CORRECT ANSWER : A
Rationale: Hashimoto's thyroiditis is an autoimmune condition characterized by the presence of
anti-thyroid peroxidase (TPO) and anti-thyroglobulin antibodies. Option B is nonspecific,
Option C is associated with Graves' disease, and Option D is not a diagnostic marker for
Hashimoto's.
7. In the management of a patient with stable angina, which medication is recommended as the
first-line therapy to improve survival and reduce ischemic symptoms?
A. Diltiazem
B. Amlodipine
C. Metoprolol
D. Isosorbide mononitrate
Answer: C
CORRECT ANSWER : C
Rationale: Beta-blockers like metoprolol are first-line for angina as they reduce myocardial
oxygen demand by lowering heart rate and contractility and have been shown to improve
survival. Calcium channel blockers (A and B) and nitrates (D) are useful for symptom relief but
do not offer the same mortality benefit in the absence of specific contraindications to beta-
blockers.
8. A 68-year-old patient with COPD reports increased sputum production and purulence. Which
clinical decision is most consistent with the management of an acute exacerbation of chronic
bronchitis?
i exam with questions and answers/plus a
rationale updated 2026 a+/instant download pdf
Table of Contents
1. Advanced Health Assessment and Diagnostic Reasoning
2. Pharmacotherapeutics for Primary Care
3. Advanced Pathophysiology of Chronic Conditions
4. Professional Role Development and Legal/Ethical Standards
5. Evidence-Based Practice and Clinical Decision-Making
1. An elderly patient with a history of heart failure presents with increased dyspnea and bilateral
pedal edema. After auscultating an S3 gallop, which diagnostic interpretation is most clinically
appropriate?
A. The presence of an S3 indicates early diastolic filling resistance common in healthy elderly
adults.
B. The S3 is a sensitive marker for left ventricular systolic dysfunction and increased filling
pressures.
C. The S3 indicates the need for immediate administration of calcium channel blockers to
decrease contractility.
D. The S3 suggests primary pulmonary hypertension requiring an urgent referral for right-heart
catheterization.
Answer: B
CORRECT ANSWER : B
, Rationale: An S3 gallop in an elderly patient with heart failure signifies ventricular dilation and
increased filling pressure, often associated with systolic dysfunction. Option A is incorrect as S3
is pathological in this age group, not a normal finding. Option C is inappropriate as calcium
channel blockers are generally avoided in heart failure with reduced ejection fraction, and D is
incorrect because the finding points to left-sided issues, not pulmonary hypertension.
2. A patient being treated for hypertension with an ACE inhibitor develops a persistent, dry cough.
What is the most likely mechanism, and what is the appropriate management strategy?
A. Bronchospasm due to bradykinin accumulation; switch the patient to an ARB.
B. Pulmonary edema due to fluid retention; increase the dose of the ACE inhibitor.
C. Histamine release secondary to mast cell activation; prescribe an antihistamine.
D. Direct airway irritation from the drug molecule; continue treatment as tolerance will develop.
Answer: A
CORRECT ANSWER : A
Rationale: ACE inhibitors prevent the breakdown of bradykinin, leading to its accumulation in
the lungs, which causes a dry cough. The standard management is to switch the patient to an
Angiotensin Receptor Blocker (ARB), which does not affect bradykinin metabolism. Options B,
C, and D are incorrect because they misidentify the mechanism and provide clinically
inappropriate management.
3. A 55-year-old patient with type 2 diabetes and stable chronic kidney disease (CKD) requires
medication adjustment. Which class of medication is prioritized for its renal protective benefits
in this clinical scenario?
A. Sulfonylureas
B. Thiazolidinediones
C. Sodium-glucose cotransporter-2 (SGLT2) inhibitors
D. Dipeptidyl peptidase-4 (DPP-4) inhibitors
Answer: C
CORRECT ANSWER : C
Rationale: SGLT2 inhibitors demonstrate significant renal protective effects in patients with
diabetes and CKD by reducing hyperfiltration and slowing disease progression. Sulfonylureas,
DPP-4 inhibitors, and Thiazolidinediones (Options A, B, and D) do not provide the same
, evidence-based renal protection and may have contraindications or limited benefits in advanced
CKD.
4. A patient presents with acute onset of severe, unilateral headache associated with photophobia
and nausea. Which finding in the physical examination would most strongly necessitate urgent
neuroimaging to rule out secondary pathology?
A. Normal neurological examination with history of similar headaches.
B. Presence of bilateral temporal tenderness and elevated ESR.
C. New-onset neurological deficit or "thunderclap" character of the headache.
D. Pain that is relieved by NSAIDs and dark, quiet environments.
Answer: C
CORRECT ANSWER : C
Rationale: A "thunderclap" headache or new-onset neurological deficit indicates a potential
intracranial emergency like subarachnoid hemorrhage or mass effect, requiring immediate
imaging. Option A describes a likely migraine, B suggests giant cell arteritis, and D is highly
characteristic of a primary migraine disorder.
5. A patient with persistent asthma is poorly controlled despite using a low-dose inhaled
corticosteroid (ICS). According to current GINA guidelines, what is the preferred next step in
management?
A. Increase the dose of the ICS.
B. Add a long-acting beta-agonist (LABA).
C. Add a short-acting beta-agonist (SABA) for daily use.
D. Transition to oral systemic corticosteroids.
Answer: B
CORRECT ANSWER : B
Rationale: For patients not controlled on low-dose ICS, the addition of a LABA is the preferred
step-up therapy to improve symptom control and lung function. Simply increasing the ICS dose
(Option A) is less effective than adding a controller agent, and daily SABA use (Option C) is
contraindicated. Systemic steroids (Option D) are reserved for severe exacerbations, not
maintenance.
, 6. A patient presents with elevated TSH and low free T4. Which laboratory finding would be most
consistent with Hashimoto's thyroiditis?
A. Elevated thyroglobulin antibodies.
B. Low serum thyroglobulin levels.
C. Suppressed thyroid-stimulating immunoglobulin (TSI).
D. Decreased erythrocyte sedimentation rate (ESR).
Answer: A
CORRECT ANSWER : A
Rationale: Hashimoto's thyroiditis is an autoimmune condition characterized by the presence of
anti-thyroid peroxidase (TPO) and anti-thyroglobulin antibodies. Option B is nonspecific,
Option C is associated with Graves' disease, and Option D is not a diagnostic marker for
Hashimoto's.
7. In the management of a patient with stable angina, which medication is recommended as the
first-line therapy to improve survival and reduce ischemic symptoms?
A. Diltiazem
B. Amlodipine
C. Metoprolol
D. Isosorbide mononitrate
Answer: C
CORRECT ANSWER : C
Rationale: Beta-blockers like metoprolol are first-line for angina as they reduce myocardial
oxygen demand by lowering heart rate and contractility and have been shown to improve
survival. Calcium channel blockers (A and B) and nitrates (D) are useful for symptom relief but
do not offer the same mortality benefit in the absence of specific contraindications to beta-
blockers.
8. A 68-year-old patient with COPD reports increased sputum production and purulence. Which
clinical decision is most consistent with the management of an acute exacerbation of chronic
bronchitis?
